Abstract 15018: Is Thirst a Marker or Cause of Complicated Heart Failure Admissions?
Sunit‐Preet Chaudhry(St. Vincent Hospital), Lynne W. Stevenson(Vanderbilt University Medical Center), Adriana Luk(Mount Sinai Hospital), Deepa M. Gopal(Boston University), Syed Mahmood(NewYork–Presbyterian Hospital), D. Marshall Brinkley(Vanderbilt University Medical Center), Neal K. Lakdawala(Brigham and Women's Hospital), John D. Groarke(Edinburgh Cancer Research)
Circulation
November 11, 2016
Cited by 0
Related Papers
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Truncations of Titin Causing Dilated Cardiomyopathy
|New England Journal of Medicine|2012|1.5k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
|Circulation|2018|837